Adherium Appoints New CFO
September 19, 2017 08:00 ET
|
Adherium
SAN MATEO, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the appointment of Timothy...
Adherium Receives U.S. 510(K) Clearance for Next Generation Smartinhaler for AstraZeneca’s Symbicort Aerosol Inhaler
September 01, 2017 09:00 ET
|
Adherium
MELBOURNE, Australia, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced U.S. Food and Drug...
Adherium Appoints New CEO to Drive Global Growth
June 09, 2017 10:13 ET
|
Adherium
MELBOURNE, Australia, June 09, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
UK’s NICE acknowledges Adherium’s Smartinhaler™ more effective than current practice in improving adherence to asthma medication
January 12, 2017 07:00 ET
|
Adherium
MELBOURNE, Australia, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (‘Adherium’ or the ‘Company’) (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication...
Adherium appoints digital health pioneer to lead European business development
January 10, 2017 09:16 ET
|
Adherium
Digital health veteran to join expanding global team MELBOURNE, Australia, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address...
Adherium’s Smartinhaler™ Technology Chosen for Major Asthma Initiative
December 09, 2016 07:00 ET
|
Adherium
MELBOURNE, Australia, Dec. 09, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Independent clinical study shows Adherium’s Smartinhaler™ dramatically improves clinical outcomes and medication adherence in children with asthma
November 17, 2016 07:00 ET
|
Adherium
Five-fold reduction in asthma-related hospitalisations observed in patients using Adherium’s Smartinhaler™Smartinhaler™ use resulted in sustained increase in medication adherence and significant...
Adherium Announces Key Technology Patent Granted in US
October 20, 2016 07:00 ET
|
Adherium
MELBOURNE, Australia, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Adherium to Supply AstraZeneca Australia With Smartinhaler™ Platform for a Joint Commercial Pilot Program
August 16, 2016 07:00 ET
|
Adherium
MELBOURNE, Australia, Aug. 16, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Adherium Executes $8m Share Placement to Fidelity International
July 20, 2016 07:00 ET
|
Adherium
MELBOURNE, Australia, July 20, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR) announces that it has entered into a binding agreement for an $8 million share placement to Fidelity International,...